Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round. This story matters for Technology readers tracking satellite. Reported by techcrunch.com. Read the full original at the source link below.
Originally reported by techcrunch.com. SatelliteNews.com curates and briefs the technology stories that matter. Our editorial policy →
Get the daily satellite signal